Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma</p>
Mahmoud M. A. Elsayed, Mahmoud E. Mostafa, Eman Alaaeldin, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 8445-8467
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
Fanhua Kong, Qifa Ye, Xiongying Miao, et al.
Theranostics (2021) Vol. 11, Iss. 11, pp. 5464-5490
Open Access | Times Cited: 132
Tailoring of Novel Azithromycin-Loaded Zinc Oxide Nanoparticles for Wound Healing
Mohammed S. Saddik, Mahmoud M. A. Elsayed, Mohamed A. El‐Mokhtar, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 111-111
Open Access | Times Cited: 109
Application of carbon nanotubes in sensing/monitoring of pancreas and liver cancer
Elham Ahmadian, Dawid Janas, Aziz Eftekhari, et al.
Chemosphere (2022) Vol. 302, pp. 134826-134826
Closed Access | Times Cited: 85
<p>Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities</p>
Umme Ruman, Sharida Fakurazi, Mas Jaffri Masarudin, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 1437-1456
Open Access | Times Cited: 128
Novel Green Biosynthesis of 5-Fluorouracil Chromium Nanoparticles Using Harpullia pendula Extract for Treatment of Colorectal Cancer
Mohammed S. Saddik, Mahmoud M. A. Elsayed, Mohamed Salaheldin A. Abdelkader, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 226-226
Open Access | Times Cited: 69
Topical Nano-Vesicular Spanlastics of Celecoxib: Enhanced Anti-Inflammatory Effect and Down-Regulation of TNF-α, NF-кB and COX-2 in Complete Freund’s Adjuvant-Induced Arthritis Model in Rats
Eman Alaaeldin, Heba A. Abou‐Taleb, Soad A. Mohamad, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 133-145
Open Access | Times Cited: 56
Smart chitosan-PLGA nanocarriers functionalized with surface folic acid ligands against lung cancer cells
Asghar Narmani, Saeid Ganji, Maryam Amirishoar, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125554-125554
Open Access | Times Cited: 25
Development and optimization of vildagliptin solid lipid nanoparticles loaded ocuserts for controlled ocular delivery: A promising approach towards treating diabetic retinopathy
H. E. Ramadan, Mahmoud M. A. Elsayed, Amani Elsayed, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100232-100232
Open Access | Times Cited: 8
Synthesis and Characterization of Chitosan-Based Nanodelivery Systems to Enhance the Anticancer Effect of Sorafenib Drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma Cells
Umme Ruman, Kalaivani Buskaran, Giorgia Pastorin, et al.
Nanomaterials (2021) Vol. 11, Iss. 2, pp. 497-497
Open Access | Times Cited: 51
Theoretical investigation on the reactive and interaction properties of sorafenib – DFT, AIM, spectroscopic and Hirshfeld analysis, docking and dynamics simulation
Y. Sheena Mary, Y. Shyma Mary, Ali Shokuhi Rad, et al.
Journal of Molecular Liquids (2021) Vol. 330, pp. 115652-115652
Closed Access | Times Cited: 45
Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma
Mahmoud M. A. Elsayed, Tarek M. Okda, Gamal M. K. Atwa, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 648-648
Open Access | Times Cited: 41
Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology
Mahmoud M. A. Elsayed, Moustafa O. Aboelez, Bakheet Elsadek, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 880-880
Open Access | Times Cited: 37
Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer
Ahmed A. El-Shenawy, Mahmoud M. A. Elsayed, Gamal M. K. Atwa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 680-680
Open Access | Times Cited: 19
The role of nanoparticles and nanomaterials in cancer diagnosis and treatment: a comprehensive review.
Hongwen Lan, Muhammad Jamil, Gaotan Ke, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5751-5784
Closed Access | Times Cited: 18
Kiwi-derived extracellular vesicles for oral delivery of sorafenib
Zhou Fang, Mengdi Song, Keqiang Lai, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106604-106604
Open Access | Times Cited: 16
Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery
György Babos, Joanna Rydz, Michał Kawalec, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7312-7312
Open Access | Times Cited: 48
Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study
Mahmoud M. A. Elsayed, Moustafa O. Aboelez, Mohamed S. Mohamed, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1629-1629
Open Access | Times Cited: 26
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 5
A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma
Mohammed S. Saddik, Mahmoud M. A. Elsayed, Amany A. Abdel-Rheem, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1845-1845
Open Access | Times Cited: 19
Lipid core-chitosan shell hybrid nanoparticles for enhanced oral bioavailability of sorafenib
Najam-us Sahar, Maleeha Gul, Ho-Ik Choi, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140030-140030
Closed Access
Dual targeting of breast cancer by chitosan/poly lactic-co-glycolic acid nanodelivery systems: Surface activation with folic acid/aptamers, and co-encapsulated with Sorafenib and quercetin
Asghar Narmani, Saeid Ganji, Maryam Amirishoar, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100695-100695
Open Access
Nanomaterials for liver cancer targeting: research progress and future prospects
Jiahong Xu, Yefu Liu
Frontiers in Immunology (2025) Vol. 16
Open Access
Liver cancer: Current and new drug delivery systems
Samson A. Adeyemi, Lindokuhle M. Ngema, Yahya E. Choonara
Elsevier eBooks (2025), pp. 1-13
Closed Access
Insights into the history and trends of nanotechnology for the treatment of hepatocellular carcinoma: a bibliometric-based visual analysis
Yulei Zhao, Xingxin Wang, Xiaoman Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Stimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment
Dipika Mandal, Paramita Paul, Manas Bhowmik
Elsevier eBooks (2021), pp. 201-232
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top